Ligand Pharmaceuticals Inc (LGND): Total Assets
$1.56B
As of 2025-12-31
$2.19B
As of 2026-06-30
+27.0%
3-year compound annual growth
+2.8%
5-year compound annual growth
+12.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.56B | +65.7% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $941.77M | +19.6% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $787.22M | +3.2% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $762.67M | -41.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $1.30B | -4.7% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $1.36B | -8.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $1.49B | +18.6% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $1.26B | +87.9% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $671.02M | +11.5% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $601.59M | +19.6% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $503.06M | +95.0% | 2017-02-28, Balance as of period end |
| 2014-12-31 | $258.03M | +146.4% | 2016-11-14, Balance as of period end |
| 2013-12-31 | $104.71M | +0.4% | 2015-02-23, Balance as of period end |
| 2012-12-31 | $104.26M | -13.5% | 2014-12-12, Balance as of period end |
| 2011-12-31 | $120.58M | +59.6% | 2013-03-14, Balance as of period end |
| 2010-12-31 | $75.56M | n/a | 2012-11-14, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $1.56B | +65.7% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $817.15M | +193.0% |
| Harrow, Inc. (HROW) | 2025-12-31 | $399.48M | +2.7% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $717.90M | -34.2% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $726.16M | -11.8% |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | $1.14B | -1.0% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $383.53M | +18.7% |
| Keros Therapeutics, Inc. (KROS) | 2025-12-31 | $338.02M | -45.1% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $396.90M | +13.1% |
Compare LGND, VREOF, HROW, ARVN side by side · Screen every company in Pharmaceutical Preparations ↗